Table 1. Phosphodiesterase-5 Inhibitor Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Phosphodiesterase-5 Inhibitor Market Restraints

Table 3. Phosphodiesterase-5 Inhibitor Market Trends

Table 4. Phosphodiesterase-5 Inhibitor Industry Policy

Table 5. Global Phosphodiesterase-5 Inhibitor Revenue by Company, 2018-2023, US$ million

Table 6. Global Phosphodiesterase-5 Inhibitor Revenue Market Share by Company, 2018-2023

Table 7. Global Phosphodiesterase-5 Inhibitor Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Phosphodiesterase-5 Inhibitor Sales Volume Market Share by Company, 2018-2023

Table 9. Global Phosphodiesterase-5 Inhibitor Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Phosphodiesterase-5 Inhibitor Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Phosphodiesterase-5 Inhibitor Mergers & Acquisitions, Expansion Plans

Table 12. Global Phosphodiesterase-5 Inhibitor Manufacturers Product Type

Table 13. China Phosphodiesterase-5 Inhibitor Revenue by Company, 2018-2023, US$ million

Table 14. China Phosphodiesterase-5 Inhibitor Revenue Market Share by Company, 2018-2023

Table 15. China Phosphodiesterase-5 Inhibitor Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Phosphodiesterase-5 Inhibitor Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Phosphodiesterase-5 Inhibitor Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Phosphodiesterase-5 Inhibitor Import & Export Trends

Table 19. Main Sources of China Phosphodiesterase-5 Inhibitor Import

Table 20. Export Destination of China Phosphodiesterase-5 Inhibitor

Table 21. Global Headquarters and Manufacturing Base of Phosphodiesterase-5 Inhibitor Manufacturers

Table 22. Global Major Manufacturers, Phosphodiesterase-5 Inhibitor Capacity Expansion and Future Plans

Table 23. Global Phosphodiesterase-5 Inhibitor Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Phosphodiesterase-5 Inhibitor Production by Region, 2018-2023, (K Units)

Table 25. Global Phosphodiesterase-5 Inhibitor Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Phosphodiesterase-5 Inhibitor Upstream (Raw Materials)

Table 27. Global Phosphodiesterase-5 Inhibitor Typical Customers

Table 28. Phosphodiesterase-5 Inhibitor Typical Distributors

Table 29. By Type, Global Phosphodiesterase-5 Inhibitor Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Phosphodiesterase-5 Inhibitor Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Phosphodiesterase-5 Inhibitor Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Phosphodiesterase-5 Inhibitor Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Phosphodiesterase-5 Inhibitor Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Phosphodiesterase-5 Inhibitor Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Phosphodiesterase-5 Inhibitor Revenue Market Share, 2018-2029

Table 37. By Country, Global Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2018-2029

Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 40. Pfizer Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 41. Pfizer Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Pfizer Company Profile and Main Business

Table 43. Pfizer Recent Developments

Table 44. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 45. Eli Lilly Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 46. Eli Lilly Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Eli Lilly Company Profile and Main Business

Table 48. Eli Lilly Recent Developments

Table 49. Baye Company Information, Head Office, Market Area and Industry Position

Table 50. Baye Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 51. Baye Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Baye Company Profile and Main Business

Table 53. Baye Recent Developments

Table 54. Dong-A Pharm Company Information, Head Office, Market Area and Industry Position

Table 55. Dong-A Pharm Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 56. Dong-A Pharm Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Dong-A Pharm Company Profile and Main Business

Table 58. Dong-A Pharm Recent Developments

Table 59. Torrent Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 60. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 61. Torrent Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Torrent Pharmaceuticals Company Profile and Main Business

Table 63. Torrent Pharmaceuticals Recent Developments

Table 64. GSK Company Information, Head Office, Market Area and Industry Position

Table 65. GSK Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 66. GSK Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. GSK Company Profile and Main Business

Table 68. GSK Recent Developments

Table 69. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 70. Abbott Laboratories Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 71. Abbott Laboratories Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Abbott Laboratories Company Profile and Main Business

Table 73. Abbott Laboratories Recent Developments

Table 74. Teva Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 75. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 76. Teva Pharmaceuticals Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Teva Pharmaceuticals Company Profile and Main Business

Table 78. Teva Pharmaceuticals Recent Developments

Table 79. Hetero Drugs Company Information, Head Office, Market Area and Industry Position

Table 80. Hetero Drugs Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 81. Hetero Drugs Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Hetero Drugs Company Profile and Main Business

Table 83. Hetero Drugs Recent Developments

Table 84. Zydus Cadila Company Information, Head Office, Market Area and Industry Position

Table 85. Zydus Cadila Phosphodiesterase-5 Inhibitor Models, Specifications and Application

Table 86. Zydus Cadila Phosphodiesterase-5 Inhibitor Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Zydus Cadila Company Profile and Main Business

Table 88. Zydus Cadila Recent Developments

List of Figure

Figure 1. Phosphodiesterase-5 Inhibitor Picture

Figure 2. By Revenue, Global Phosphodiesterase-5 Inhibitor Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Phosphodiesterase-5 Inhibitor Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Phosphodiesterase-5 Inhibitor Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Phosphodiesterase-5 Inhibitor Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Phosphodiesterase-5 Inhibitor Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Phosphodiesterase-5 Inhibitor Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Phosphodiesterase-5 Inhibitor Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Phosphodiesterase-5 Inhibitor Share of Global Market, 2018-2029

Figure 10. Global Phosphodiesterase-5 Inhibitor Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Phosphodiesterase-5 Inhibitor Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Phosphodiesterase-5 Inhibitor Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Phosphodiesterase-5 Inhibitor Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Phosphodiesterase-5 Inhibitor Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Phosphodiesterase-5 Inhibitor Domestic VS Export, 2022

Figure 16. Global Phosphodiesterase-5 Inhibitor Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Phosphodiesterase-5 Inhibitor Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Phosphodiesterase-5 Inhibitor Production Market Share & Forecast by Region, 2018-2029

Figure 19. Phosphodiesterase-5 Inhibitor Industry Chain

Figure 20. Phosphodiesterase-5 Inhibitor Procurement Model

Figure 21. Phosphodiesterase-5 Inhibitor Sales Model

Figure 22. Phosphodiesterase-5 Inhibitor Sales Channels, Direct Sales and Distribution

Figure 23. Oral Tablet

Figure 24. Oral Liquid

Figure 25. By Type, Global Phosphodiesterase-5 Inhibitor Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Phosphodiesterase-5 Inhibitor Revenue Market Share, 2018-2029

Figure 27. By Type, Global Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Phosphodiesterase-5 Inhibitor Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Pharmaceutical Company

Figure 32. Laboratory

Figure 33. Clinic

Figure 34. Others

Figure 35. By Application, Global Phosphodiesterase-5 Inhibitor Revenue, 2018-2029, US$ Million

Figure 36. By Application, Global Phosphodiesterase-5 Inhibitor Revenue Market Share, 2018-2029

Figure 37. By Application, Global Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 38. By Application, Global Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2018-2029

Figure 39. By Application, Global Phosphodiesterase-5 Inhibitor Price, 2018-2029, (US$/Unit)

Figure 40. By Region, Global Phosphodiesterase-5 Inhibitor Revenue Market Share, 2018-2029

Figure 41. By Region, Global Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2018-2029

Figure 42. North America Phosphodiesterase-5 Inhibitor Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, North America Phosphodiesterase-5 Inhibitor Revenue Market Share, 2022

Figure 44. Europe Phosphodiesterase-5 Inhibitor Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, Europe Phosphodiesterase-5 Inhibitor Revenue Market Share, 2022

Figure 46. Asia Pacific Phosphodiesterase-5 Inhibitor Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country/Region, Asia Pacific Phosphodiesterase-5 Inhibitor Revenue Market Share, 2022

Figure 48. South America Phosphodiesterase-5 Inhibitor Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, South America Phosphodiesterase-5 Inhibitor Revenue Market Share, 2022

Figure 50. Middle East & Africa Phosphodiesterase-5 Inhibitor Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. U.S. Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 52. By Company, U.S. Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 53. By Type, U.S. Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 56. By Company, Europe Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 57. By Type, Europe Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 59. China Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, China Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 61. By Type, China Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, Japan Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 65. By Type, Japan Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 68. By Company, South Korea Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 69. By Type, South Korea Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 70. By Application, South Korea Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 71. Southeast Asia Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 72. By Company, Southeast Asia Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 73. By Type, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 74. By Application, Southeast Asia Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 75. India Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 76. By Company, India Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 77. By Type, India Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 78. By Application, India Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 79. Middle East & Asia Phosphodiesterase-5 Inhibitor Sales Volume, 2018-2029, (K Units)

Figure 80. By Company, Middle East & Asia Phosphodiesterase-5 Inhibitor Market Share, 2022

Figure 81. By Type, Middle East & Asia Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 82. By Application, Middle East & Asia Phosphodiesterase-5 Inhibitor Sales Volume Market Share, 2022 VS 2029

Figure 83. Research Methodology

Figure 84. Breakdown of Primary Interviews

Figure 85. Bottom-up Approaches

Figure 86. Top-down Approaches